After a long day, it might feel therapeutic to spend some time scrolling through your cellphone. But with the advent of new technologies, your cellphone might soon be pivotal to clinically validated therapeutics.
Megan Coder (PharmD ’09) keeps this vision in mind as she helps to lead an international non-profit association that’s focused on advancing digital therapeutics companies: the Digital Therapeutics Alliance (DTA). As a co-founder and chief policy officer, Coder is working to develop global standards for digital therapeutics, like those that exist for pharmaceuticals, backed by studies, evaluation, and ingredient information.